HIKAL
Back to All Ratios
|
HIKAL Last 5 Year EPS Growth History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EPS Growth(%) | -51.16 | 20.55 | 57.68 | -18.08 | -11.02 |
What is the latest EPS Growth ratio of HIKAL ?
Year | EPS Growth |
---|---|
Mar2023 | -51.16 |
Mar2022 | 20.55 |
Mar2021 | 57.68 |
Mar2020 | -18.08 |
Mar2019 | -11.02 |
How is EPS Growth of HIKAL Trending?
Years | EPS Growth | % Change | |
---|---|---|---|
Mar2023 | -51.16 | Negative | |
Mar2022 | 20.55 | -64.37 | |
Mar2021 | 57.68 | Positive | |
Mar2020 | -18.08 | Negative | |
Mar2019 | -11.02 | - |
Other Financial Ratios of HIKAL
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EPS Growth ratio of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,574.5 Cr | -3.8% | 3.5% | 0.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -3.8% |
3.5% |
0.3% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses